Pulmonary Disease, Chronic Obstructive (COPD)
Conditions
Keywords
Chest expansion, peak expiratory flow rate, dyspnea
Brief summary
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing. Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management
Detailed description
Chronic Obstructive pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratory condition may lead to shallow breathing. Breathing exercises help to manage hyperventilation often seen in copd patients. To handle respiratory complications patients are advised to practice brathing techniques along with pharmacological management. Total 46 participants are allocated divided into two group. Group A will perform Pilates breathing along with pharmacological management and group B will perform Pursed-lip breathing along with pharmacological management. Hence objective of study is to compare the effects of pilates breathing techniques along with pharmacological management versus pursed-lip breathing along with pharmacological management on chest expansion, peak expiratory flow rate, dyspnea and quality of life in patients with chronic obstructive lung disease
Interventions
PROCEDUREPilates Breathing Technique along with standard pharmacological management
Patients in this group will receive pilates breathing technique along with pharmacological management. A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose. While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.
PROCEDUREPursed-lip breathing along with pharmacological management
Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home. The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist
Sponsors
Foundation University Islamabad
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This is a randomized controlled trial having two groups. One group (interventional group) wil receive Pilates breathing along with pharmacological management and the other group (control group) will perform Pursed-lip breathing along with pharmacological management.
Eligibility
Sex/Gender
ALL
Age
40 Years to 64 Years
Healthy volunteers
No
Inclusion criteria
* Age between 40-64 years * Both genders (male and female) * Grade 1-3 on mMRC scale of dyspnea * COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Exclusion criteria
* Moderate, severe and very severe stage of COPD according to GOLD classification * Patients having acute exerbation of COPD * Patients diagnosed with acute infection * Patients unable to follow command and instructions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Chest Expansion | 03 weeks | Evaluation will be done using inch tape (inches) for Chest Expansion |
| Peak expiratory flow rate | 03 weeks | Evaluation will be done by using Peak flow meter |
| Dyspnea | 03 weeks | Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC) |
Countries
Pakistan
Contacts
Primary ContactSana Kalim, DPT
Backup ContactZara Khalid, PhD
Outcome results
None listed